NHIA to expand availability of lung cancer drug Tagrisso

The National Health Insurance Administration (NHIA) said Monday it expects to expand coverage of Tagrisso, a third-generation targeted drug, for more lung cancer patients from October.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)